View Single Post
Old 07-24-2007, 02:13 PM   #3
Lani
Senior Member
 
Join Date: Mar 2006
Posts: 4,783
at conferences I have heard up to 6 months quoted

There was a paper with Pamela Klein as one of the authors regarding the fact that the metabolism/clearance rate difference between fast and slow metabolizers/clearers of the monoclonal antibody varies by as much as 43% in patients with metastatic breast cancer (never saw a paper for those with early breast cancer) so the result may vary person to person anyway.

Hope this helps.
Lani is offline   Reply With Quote